We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$418M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$235M
3
EXEL icon
Exelixis
EXEL
+$219M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$191M
5
SJR
Shaw Communications Inc.
SJR
+$183M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$152M
2
CLVT icon
Clarivate
CLVT
+$127M
3
SGFY
Signify Health, Inc.
SGFY
+$113M
4
LHCG
LHC Group LLC
LHCG
+$111M
5
ATVI
Activision Blizzard
ATVI
+$87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFX icon
26
Equifax
EFX
$21.4B
$283M 1.55%
1,396,597
-305,900
-18% -$63.7M
BX icon
27
Blackstone
BX
$110B
$276M 1.51%
3,139,951
-109,000
-3% -$9.63M
MA icon
28
Mastercard
MA
$493B
$264M 1.44%
726,471
-189,700
-21% -$68.9M
AON icon
29
Aon
AON
$76B
$254M 1.39%
804,686
+16,600
+2% +$5.14M
NYT icon
30
New York Times
NYT
$10.2B
$247M 1.35%
6,354,791
+286,000
+5% +$10.5M
CSGP icon
31
CoStar Group
CSGP
$12.3B
$235M 1.28%
3,411,185
+1,131,000
+50% +$83.5M
V icon
32
Visa
V
$677B
$228M 1.24%
1,009,410
-239,600
-19% -$53.3M
XYZ
33
Block Inc
XYZ
$47.5B
$196M 1.07%
2,861,050
-356,950
-11% -$26.7M
VMW
34
DELISTED
VMware, Inc
VMW
$189M 1.03%
1,510,623
+120,000
+9% +$14.4M
BABA icon
35
Alibaba
BABA
$308B
$184M 1%
1,800,000
-861,000
-32% -$86.2M
OSH
36
DELISTED
Oak Street Health, Inc.
OSH
$174M 0.95%
+4,503,076
New +$145M
BIIB icon
37
Biogen
BIIB
$30.7B
$172M 0.94%
619,798
+27,099
+5% +$7.5M
UTHR icon
38
United Therapeutics
UTHR
$23.1B
$149M 0.81%
664,767
+8,894
+1% +$2.19M
SRPT icon
39
Sarepta Therapeutics
SRPT
$1.77B
$126M 0.69%
913,300
-15,600
-2% -$2.02M
HUM icon
40
Humana
HUM
$46.2B
$119M 0.65%
244,661
-25,739
-10% -$12.7M
RXDX
41
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$118M 0.65%
1,100,806
+955,706
+659% +$110M
MASI
42
DELISTED
Masimo
MASI
$117M 0.64%
631,649
-126,851
-17% -$21.4M
BEAM icon
43
Beam Therapeutics
BEAM
$2.84B
$105M 0.57%
3,431,921
+32,000
+0.9% +$1.26M
BEKE icon
44
KE Holdings
BEKE
$18.8B
$89.7M 0.49%
4,758,500
-1,000,000
-17% -$18.5M
PCG icon
45
PG&E
PCG
$38.5B
$80.9M 0.44%
5,005,142
-150,000
-3% -$2.37M
LU icon
46
Lufax Holding
LU
$1.3B
$78.1M 0.43%
9,574,136
-34,964
-0.4% -$335K
PACB icon
47
Pacific Biosciences
PACB
$370M
$73.6M 0.4%
6,355,120
+2,350,720
+59% +$23.4M
RVMD icon
48
Revolution Medicines
RVMD
$44B
$71.1M 0.39%
3,283,600
+1,585,585
+93% +$39M
ENTA icon
49
Enanta Pharmaceuticals
ENTA
$400M
$62.7M 0.34%
1,550,000
– –
PTGX icon
50
Protagonist Therapeutics
PTGX
$9.44B
$60.1M 0.33%
2,615,014
-1,036,873
-28% -$17.4M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Farallon Capital Management held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in UnitedHealth worth $409M.

  • Farallon Capital Management's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Farallon Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Farallon Capital Management fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Farallon Capital Management opened 14 new positions and closed 63 in Q1 2023.
  • Farallon Capital Management's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.